Irritable bowel syndrome and other functional gastrointestinal disorders

Journal of Clinical Gastroenterology

Volumn 45, Issue SUPPL. 2, 2011, Pages

  Şimşek, Ilkay ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

bowel; functional; gastrointestinal; IBS; irritable

Indexed keywords

CYTOKINE;

CELIAC DISEASE; CELL MOTILITY; CELL SECRETION; CHRONIC FATIGUE SYNDROME; COLON FLORA; COMORBIDITY; DIAGNOSTIC TEST; DIGESTIVE SYSTEM FUNCTION DISORDER; FIBROMYALGIA; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACTOSE INTOLERANCE; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

CELIAC DISEASE; COMORBIDITY; ESOPHAGEAL DISEASES; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; LACTOSE INTOLERANCE; PREVALENCE;

EID: 79958787627     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31821fbd6f     Document Type: Review

References (25)

1. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.
2. Noh YW, Jung HK, Kim SE, et al. Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III Criteria. J Neurogastroenterol Motil. 2010;16:148-56.
3. Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep. 2005;7:264-271. (Pubitemid 41223338)
4. Locke GR III, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17:29-34. (Pubitemid 40204009)
5. Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456.
6. Jung HK, Halder S, McNally M, et al. Overlap of gastrooesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007;26:453-461. (Pubitemid 47063139)
7. Pimentel M, Rossi F, Chow EJ, et al. Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol. 2002;34:221-224. (Pubitemid 34177372)
8. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-1479.
9. Ford AC, Marwaha A, Lim A, et al. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010;8:401-409.
10. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390.
11. Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil. 2010;16:251-257.
12. Ohman L, Simren M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201-215. (Pubitemid 46196435)
13. Beesley H, Rhodes J, Salmon P. Anger and childhood sexual abuse are independently associated with irritable bowel syndrome. Br J Health Psychol. 2010;15:389-399.
14. Camilleri M. Mechanisms in IBS: something old, something new, something borrowed. Neurogastroenterol Motil. 2005;17:311-316.
15. Clarke G, Quigley EM, Cryan JF, et al. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med. 2009;15:478-489.
16. Hotoleanu C, Popp R, Trifa AP, et al. Genetic determination of irritable bowel syndrome. World J Gastroenterol. 2008;14:6636-6640.
17. Petitpierre M, Gumowski P, Girard JP. Irritable bowel syndrome and hypersensitivity to food. Ann Allergy. 1985;54:538-540. (Pubitemid 15062795)
18. Drisko J, Bischoff B, Hall M, et al. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr. 2006;25:514-522. (Pubitemid 46175667)
19. Posserud I, Stotzer PO, Björnsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802-808.
20. Malinen E, Rinttilä T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100:373-382. (Pubitemid 40314522)
21. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804-811.
22. Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol. 2000;95:1231-1238. (Pubitemid 30263518)
23. Aerssens J, Camilleri M, Talloen W, et al. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008;6:194-205. (Pubitemid 351172944)
24. Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26-37. (Pubitemid 46108761)
25. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693-702. (Pubitemid 38298317)